Zobrazeno 1 - 10 of 26 pro vyhledávání: '"Olaf, Weingart"'
2
EbM von unten: Sind Fragen nach Evidenz zu klinischen Alltagsproblemen beantwortbar?
Autor: Olaf Weingart, Wolfgang A. Blank
Publikováno v: Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen. 103:425-430
Many physicians agree on the advantages of using Evidence-based Medicine (EbM) in daily practice, but they do not make use of this method very often. One reason for this lack of EbM implementation is that it is difficult to access clinically relevant
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::75a2de29fa2c3af89fdb10a0113688dc
https://doi.org/10.1016/j.zefq.2009.03.025
Zobrazit plný text záznamu
3
Recombinant Human Erythropoietins and Cancer Patients: Updated Meta-Analysis of 57 Studies Including 9353 Patients
Autor: Julia Bohlius, Sven Trelle, Olaf Weingart, Jayne S. Wilson, Simon Langensiepen, Chris Hyde, Margaret Piper, Susan Bayliss, Josie Sandercock, Charles L. Bennett, Benjamin Djulbegovic, Guido Schwarzer, Jerome Seidenfeld, Andreas Engert
Publikováno v: JNCI: Journal of the National Cancer Institute. 98:708-714
This is an updated systematic review of 57 trials and 9353 cancer patients from articles, abstracts, and reports published between January 1, 1985, and April 30, 2005, on the effects of epoetin alfa and beta (i.e., epoetin) and darbepoetin alfa (i.e.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e49aa15847d4e633726466e49390d66
https://doi.org/10.1093/jnci/djj189
Zobrazit plný text záznamu
5
Allogeneic stem cell transplant in adult patients with acute myelogenous leukemia: a systematic analysis of international guidelines and recommendations
Autor: Frauke Naumann, Olaf Weingart, Kai Hübel, Keith Wheatley, Maximilian M. Fresen, Julia Bohlius, Andreas Engert
Publikováno v: Leukemialymphoma. 52(3)
In patients with acute myelogenous leukemia, published guidelines and treatment recommendations are usually the basis for starting the work-up process for allogeneic transplant. However, only consistent recommendations would allow a standardized clin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19b42fb20834ab28de36c6ad579c7f36
https://pubmed.ncbi.nlm.nih.gov/21323525
Zobrazit plný text záznamu
6
[EbM from the bottom up: are questions asking for evidence in daily clinical practice answerable?---a report from a pilot test to assist general practitioners with using evidence-based medicine]
Autor: Wolfgang, Blank, Olaf, Weingart
Publikováno v: Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen. 103(7)
Many physicians agree on the advantages of using Evidence-based Medicine (EbM) in daily practice, but they do not make use of this method very often. One reason for this lack of EbM implementation is that it is difficult to access clinically relevant
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f0a1dd8d4d6d79e947db4d118206f717
https://pubmed.ncbi.nlm.nih.gov/19839529
Zobrazit plný text záznamu
9
Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data
Autor: Sven Trelle, Matthias Egger, Isabelle Ray-Coquard, David P. Steensma, Olaf Weingart, Benjamin Djulbegovic, Corinne Brillant, Guido Schwarzer, Maryann Napoli, Julia Bohlius, Volker Moebus, Andreas Engert, Kurt Schmidlin, Martin F. Fey, Martin Schumacher, Mike Clarke, Dirk Rades, Sabine Kluge, Jerome Seidenfeld, Michael Untch, Margaret Piper, Gillian Thomas, Marcel Zwahlen
Publikováno v: The Cochrane Library
Scopus-Elsevier
Bohlius, Julia; Schmidlin, Kurt; Brillant, Corinne; Schwarzer, Guido; Trelle, Sven; Seidenfeld, Jerome; Zwahlen, Marcel; Clarke, Mike J; Weingart, Olaf; Kluge, Sabine; Piper, Margaret; Napoli, Maryann; Rades, Dirk; Steensma, David; Djulbegovic, Benjamin; Fey, Martin F; Ray-Coquard, Isabelle; Moebus, Volker; Thomas, Gillian; Untch, Michael; ... (2009). Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data. Cochrane database of systematic reviews, 2009(3), CD007303. Chichester: WileyInterscience 10.1002/14651858.CD007303.pub2
Cochrane Database Syst Rev
BACKGROUND: Erythropoiesis-stimulating agents (ESAs) reduce anemia in cancer patients and may improve quality of life, but there are concerns that ESAs might increase mortality. OBJECTIVES: Our objectives were to examine the effect of ESAs and identi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5137074c74ad3d377fcbfeb6f97c0875
https://doi.org/10.1002/14651858.cd007303.pub2
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje